Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
Clinical trial NCT04396366 · TERMINATED
Trial details
- NCT number
- NCT04396366
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-02
- Primary completion
- 2023-06-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.